Navigation Links
Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid

May 25-28; London, United Kingdom.
  • Schlesinger N, Alten R, Bardin T, et al. Efficacy of canakinumab versus triamcinolone acetonide in acute gouty arthritis patients: results of the Beta-RELIEVED II study (REsponse in acute fLare and In prEVEntion of episoDes of re-flare in gout).  Poster (THU0019) presented at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  • Schlesinger N, Alten R, Bardin T, et al. Efficacy of canakinumab vs triamcinolone acetonide in preventing recurrent flares in acute gouty arthritis patients contraindicated, intolerated or unresponsive to NSAIDs and/or colchicine. Abstract (EULAR11-2018 for OP0107) at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  • ILARIS [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2009.

  • Novartis Media RelationsTina TuttleNovartis US Pharma Communications

    +1 862 778 1625 (direct)

    +1 862 222 6092 (mobile)

    Michael BillingsNovartis US Pharma Communications

    +1 862 778 86565 (direct)

    +1 201 400 1854 (mobile)

    michael.billings@novartis.comAnna FrableNovartis US Pharma Communications

    +1 862 778 5388 (direct)

    +1 732 673 5262 (mobile)


    Novartis Investor RelationsCentral phone:+41 61 324 7944Susanne Schaffert

    +41 61 324 7944

    North America:Pierre-Michel Bringer

    +41 61 324 1065

    Richard Jarvis

    +1 212 830 2433Thomas Hungerbuehler

    +41 61 324 8425

    Jill Pozarek

    +1 212 830 2445Isabella Zinck

    +41 61 324 7188

    Edwin Valeriano

    +1 212 830 2456e-mail

    SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
    3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
    4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
    5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
    6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
    7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
    8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
    9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
    10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
    11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
    Post Your Comments:
    (Date:10/25/2014)... 24, 2014 Advanced Photonix ® (NYSE MKT: ... 2014) financial results on Monday, November 10, 2014. A press ... close of the market and the Company will host a ... p.m. EDT on the same day. Participating in ... Director), Rob Risser (COO and Director), and ...
    (Date:10/25/2014)... Oct. 24, 2014  In 2008, two of Dr. ... of multiple controlled substances, on a regular basis, that ... that Dr. Gurney was practicing "all the time" while ... of his employees said that Dr. Gurney was prone ... patients." Dr. Gurney,s behavior became increasingly erratic ...
    (Date:10/25/2014)... CHAPEL HILL, N.C. , Oct. 24, 2014 ... Consortium to provide Medical Affairs leaders with a ... they face. The consortium has developed a mechanism ... roundtable discussions where leaders discuss key findings from ... Best Practices has completed the analysis for the ...
    Breaking Medicine Technology:Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 3Strong Participation in Best Practices' Medical Affairs Consortium Survey 2
    ... Tenn., Oct. 27 Cumberland Pharmaceuticals Inc. (Nasdaq: ... quarter 2009 financial results before the market opens on Tuesday, ... webcast will be held on Tuesday, November 10, 2009 at ... participate on the call, please dial 888-417-8462 (for U.S. callers) ...
    ... , DENVER, Oct. 27 A Denver ophthalmologist recently became ... lens during cataract surgery, raising the bar for patient care ... his patients. , Dr. Paul Cutarelli, director of Cutarelli Vision ... nanoFLEX lens in October in the eye of a 70-year-old ...
    Cached Medicine Technology:Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009 2Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 2Denver-Ft. Collins Ophthalmologist First in Colorado to Implant nanoFLEX Lens 3
    (Date:10/25/2014)... Background: , In 1998 Bob Savage founded ... pioneer in the field of establishing recovery community organizations. ... and when he retired, he set out to answer a ... , 1. Where are the people in ... , 2. Can the recovery community be organized to advocate ...
    (Date:10/25/2014)... 25, 2014 has a variety ... selection at affordable prices. Bob Seger & The Silver ... and Nationwide Arena are going on sale October 25 ... Here to browse the selection of tickets for ... , The famous singer is touring North America beginning ...
    (Date:10/25/2014)... CT (PRWEB) October 25, 2014 Limbkeepers® ... upcoming episode of Innovations with Ed Begley Jr, airing ... times TBA. , In this episode, Innovations will focus ... helping to protect fragile, thinning skin on arms, hands, ... will learn about these versatile products, which help reduce ...
    (Date:10/25/2014)... -- Researchers who discovered antibiotics in farmed and ... concern. The use of antibiotics in animals, ... contribute to the development of antibiotic-resistant bacteria that ... the study. Each year in the United ... and kill about 23,000, according to the Infectious ...
    (Date:10/25/2014)... (HealthDay News) -- October,s shorter, darker days can trigger ... according to an expert. People affected by ... tired, lack motivation and even have trouble getting out ... suicide, said Dr. Angelos Halaris, a professor in the ... Chicago Stitch School of Medicine. "Seasonal affective disorder ...
    Breaking Medicine News(10 mins):Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Dark Days Here for Folks With Seasonal Depression 2
    ... Pediatric Dengue Vaccine Initiative (PDVI), a program of the ... announced today their partnership to help develop and make ... of Dengue fever, the second most widespread tropical disease ... to which over 2 billion people are exposed and ...
    ... scientists at Dartmouth Medical School and Dartmouth College, have ... changing muscle metabolism and performance. // The researchers are ... of muscle diseases. , ,The researchers ... (or AMPK) is responsible for realizing the best muscle ...
    ... While kidney failure is a serious condition that ... these patients are prone to developing another grave ... Fibrosing Dermopathy (NSF/NFD). // First recognized as a ... or tightening of the skin, resulting in pain, ...
    ... after menopause, a change thought to be due, in part, ... // ,Now, research from the University of Michigan ... certain memory functions. In a study in the new issue ... that a group of postmenopausal women showed more brain activity ...
    ... who are overweight or obese have increased blood pressure ... risk of kidney damage previously found in this group ... at the American Society of Nephrology's 39th Annual Meeting ... demonstrated that filtration pressure in the kidney was higher ...
    ... two animal caretakers sent letters to city, state and federal ... not stringent //enough in treating waste from animals that died ... disease before it was sent to the city's sewage treatment ... request of the federal and city officials to study the ...
    Cached Medicine News:Health News:Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever 2Health News:Dartmouth researchers zero-in on a gene that heightens muscle performance 2Health News:Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition 2Health News:Hormone Therapy May Improve the Trip Down Memory Lane 2Health News:Kidney Blood Flow May Explain Increased Long-Term Risks for Obese Kidney Donors 2Health News:Complaints Against US Federal lab Over-ruled by Panel 2
    Lead filled and faced bone mallet used to exert force on osteotomes, chisels, and gouges....
    Straight curette with hollow handle and round cup....
    Coarse rasp....
    Rasp with down cutting pattern....
    Medicine Products: